Dextra International, Grant Thornton Advise Spanish Biological Company Trichodex on Its Sale to Grupo Fertiberia
20 July 2022 Dextra International and Grant Thornton recently advised Trichodex, a leading biological company based in Spain, on its sale to Grupo Fertiberia. The two firms, which specialize in M&A, provided financial and legal advice to Trichodex on the transaction. Dextra International & Grant Thornton have been constantly working together since 2019 on M&A transactions for the agribusiness Industry.
Trichodex brings to Grupo Fertiberia its pioneering technology in innovative biofertilizers, biostimulants and bioprotection products, which it exports to 12 countries.
Founded in 1991, Trichodex has an R&D team that translates the results of its laboratory research into high-tech products, which are then developed at its state-of-the-art production center in Dos Hermanas, Seville. This highly integrated business model has enabled it to offer sustainable solutions adapted to the needs of farmers in different parts of the world. In addition to Spain, Trichodex markets its products in a dozen countries in Europe and Latin America.
Its products are based on patented bioprocesses selecting optimal microorganisms to produce bioactives that improve profitability and crop protection.
For Fertiberia, the acquisition is a step forward to lead the sector of innovative solutions for plant nutrition thanks to biotechnology. This purchase is part of its strategy to grow in the development of biofertilizers and biostimulants with high added value.
The financial advice was led by Ramón Galcerán, Grant Thornton, and David de Boet, Dextra International; and the legal advice was led by Álvaro Rodríguez and Ana Novoa.
Get The Newsletter Today!
